ArticleInternational journal of clinical oncology2026
Efficacy and biomarker analysis for nivolumab in cancer of unknown primary: results from an investigator-initiated expanded access program.
Junko Tanizaki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.